Who invested in Sidewinder Therapeutics?
Sidewinder Therapeutics's investors include Novartis Venture Fund, Frazier Life Sciences, OrbiMed, DCVC and Alexandria Real Estate Equities, and 4 more on record. Novartis Venture Fund led its latest round.

United States · Series B startup
One round we have observed, with the 9 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 7 months ago
Follow Sidewinder Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$137Mraised across 1 round since 2026, from 1 source
From Sidewinder Therapeutics's own website: 2 on the team.
Sidewinder Therapeutics's investors include Novartis Venture Fund, Frazier Life Sciences, OrbiMed, DCVC and Alexandria Real Estate Equities, and 4 more on record. Novartis Venture Fund led its latest round.
Sidewinder Therapeutics has raised $137M across 1 round since 2026.
Sidewinder Therapeutics's most recent round was a Series B of $137M in Apr 2026, led by Novartis Venture Fund.
Its most recent round, $137M in Apr 2026, is also its largest on record.
Sidewinder Therapeutics's first round on record, in Apr 2026, was backed by Novartis Venture Fund, Frazier Life Sciences and OrbiMed and 6 others.
Sidewinder Therapeutics's latest named round is a Series B, in Apr 2026.
Sidewinder Therapeutics is based in the United States.
Novartis Venture Fund led the Series B in 2026.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.